WHY FUNGUS IS YOUR GUT'S BEST FRIEND - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 87504901
Serial Number
87504901
Word Mark
WHY FUNGUS IS YOUR GUT'S BEST FRIEND
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2019-12-09
Filing Date
2017-06-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-03-13
Attorney Name
Law Office Assigned Location Code
M10
Employee Name
THOMAS, AMY E
Statements
Goods and Services
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; preparations in the nature of a vaginal probiotic for the treatment and/or prevention of bacterial or fungal vaginal infection; nutraceuticals for the treatment and/or prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and/or nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and/or bacterial probiotics, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; diagnostic colon test kit comprised of medical diagnostic reagents and assays for the detection of cancer, polyps, ulcers, inflammation, infection, bacteria and microorganisms; diagnostic colon cancer test kit comprised of medical diagnostic reagents and assays; colorectal cancer screening test kit comprised of medical diagnostic reagents and assays
Goods and Services
Educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy large intestine
Goods and Services
Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-07-01
Primary Code
005
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2018-02-01
Primary Code
041
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-01
Primary Code
044
Correspondences
Name
BRIAN E. TURUNG
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-07-01NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-07-31ASSIGNED TO EXAMINER
2017-08-02NON-FINAL ACTION WRITTEN
2017-08-02NON-FINAL ACTION E-MAILED
2017-08-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-01-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-01-31CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-02-01TEAS/EMAIL CORRESPONDENCE ENTERED
2018-02-01EXAMINERS AMENDMENT -WRITTEN
2018-02-01EXAMINERS AMENDMENT E-MAILED
2018-02-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-02-01EXAMINER'S AMENDMENT ENTERED
2018-02-01APPROVED FOR PUB - PRINCIPAL REGISTER
2018-02-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-03-13PUBLISHED FOR OPPOSITION
2018-03-13OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-05-08NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-10-26TEAS EXTENSION RECEIVED
2018-10-26EXTENSION 1 FILED
2018-10-26EXTENSION 1 GRANTED
2018-10-30NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-01-30AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-05-08TEAS EXTENSION RECEIVED
2019-05-08EXTENSION 2 FILED
2019-05-08EXTENSION 2 GRANTED
2019-05-10NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-12-09ABANDONMENT - NO USE STATEMENT FILED
2019-12-09ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED